跳至主要内容
临床试验/IRCT20100107003014N26
IRCT20100107003014N26招募中1 期

Comparison the efficacy of adding levofloxacin and colistin inhalation form to basic regimen of colistin and meropenem in treatment of ventilator associated pneumonia (VAP) caused by multidrug resistant pathogens: a double-blind randomized clinical trial

Mazandaran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Age older than 18 years and less than 80 years
  • Mechanical ventilation for more than 48 hours
  • Pneumonia diagnosis based on the 2016 guidelines of the Infectious Diseases Society of America (IDSA)
  • CPIS score above 6
  • Positive culture of sputum sample and growth of gram-negative bacteria resistant to treatment (MDR) (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae, etc.)

排除标准

  • Pregnancy or breastfeeding
  • History of allergy to any of the drugs Colistin, Levofloxacin and Meropenem
  • Acute respiratory distress syndrome
  • Pulmonary tuberculosis disease under treatment
  • Cystic fibrosis disease
  • Major interaction of other drugs used by the patient with levofloxacin, colistin or meropenem
  • Baseline creatinine clearance less than 15 mL/min
  • History of receiving antibiotics effective against MDR pathogens during hospitalization
  • Presence of pneumonia before intubation

研究者

相似试验

Efficacy of levofloxacin and colistin inhalation... | 临床试验